Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder: A Randomized Controlled Trial
Phase: PHASE3 | Sponsor: Lakshmi N Yatham | Compound: Psilocybin
- Status
- planned
- Institution
- Lakshmi N Yatham
- Start date
- 2025-10-01
- End date
- 2028-12-01
- Registry ID
- NCT06943573
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.